Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.91)
# 596
Out of 5,154 analysts
460
Total ratings
42.39%
Success rate
12.65%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYPT EyePoint | Maintains: Buy | $23 → $30 | $15.76 | +90.36% | 24 | Mar 5, 2026 | |
| OCS Oculis Holding AG | Maintains: Buy | $42 → $44 | $27.74 | +58.62% | 18 | Mar 4, 2026 | |
| HROW Harrow | Maintains: Buy | $69 → $70 | $36.17 | +93.53% | 8 | Mar 4, 2026 | |
| BLTE Belite Bio | Maintains: Buy | $185 → $200 | $172.57 | +15.90% | 24 | Mar 3, 2026 | |
| DRTS Alpha Tau Medical | Maintains: Buy | $9 → $12 | $7.12 | +68.54% | 22 | Feb 24, 2026 | |
| BLCO Bausch + Lomb | Maintains: Buy | $17 → $20 | $17.60 | +13.64% | 21 | Feb 23, 2026 | |
| RGNX REGENXBIO | Maintains: Buy | $34 → $32 | $8.72 | +266.97% | 15 | Feb 10, 2026 | |
| NPCE NeuroPace | Maintains: Buy | $18 → $19 | $13.60 | +39.71% | 2 | Jan 27, 2026 | |
| SMTI Sanara MedTech | Reiterates: Buy | $36 | $19.20 | +87.50% | 7 | Jan 26, 2026 | |
| LPCN Lipocine | Maintains: Buy | $7 → $15 | $8.19 | +83.15% | 6 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 → $1 | $0.21 | +383.09% | 2 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $39 → $50 | $24.67 | +102.68% | 9 | Dec 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $20.12 | +59.05% | 5 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $1.5 | $0.77 | +93.82% | 8 | Dec 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5.5 | $1.40 | +292.86% | 2 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $21 | $10.33 | +103.29% | 30 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $39 | $29.16 | +33.74% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.13 | +519.47% | 3 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $9 | $3.00 | +200.00% | 11 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $1.5 | $0.20 | +662.20% | 4 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.38 | +407.25% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.59 | +576.93% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $89 | $53.05 | +67.77% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.61 | +38.50% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.65 | +283.73% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.28 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.69 | +314.20% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.89 | +142.21% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.49 | +122.72% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.03 | +392.61% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.15 | +247.83% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.62 | +243.51% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $4.28 | +86.92% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $10.87 | +47.19% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $18.75 | +33.33% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.17 | +156.41% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.56 | +1,071.88% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.81 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $2.00 | +24,900.00% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $13.33 | +260.09% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $115.24 | -83.51% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.89 | - | 2 | Apr 16, 2020 |
EyePoint
Mar 5, 2026
Maintains: Buy
Price Target: $23 → $30
Current: $15.76
Upside: +90.36%
Oculis Holding AG
Mar 4, 2026
Maintains: Buy
Price Target: $42 → $44
Current: $27.74
Upside: +58.62%
Harrow
Mar 4, 2026
Maintains: Buy
Price Target: $69 → $70
Current: $36.17
Upside: +93.53%
Belite Bio
Mar 3, 2026
Maintains: Buy
Price Target: $185 → $200
Current: $172.57
Upside: +15.90%
Alpha Tau Medical
Feb 24, 2026
Maintains: Buy
Price Target: $9 → $12
Current: $7.12
Upside: +68.54%
Bausch + Lomb
Feb 23, 2026
Maintains: Buy
Price Target: $17 → $20
Current: $17.60
Upside: +13.64%
REGENXBIO
Feb 10, 2026
Maintains: Buy
Price Target: $34 → $32
Current: $8.72
Upside: +266.97%
NeuroPace
Jan 27, 2026
Maintains: Buy
Price Target: $18 → $19
Current: $13.60
Upside: +39.71%
Sanara MedTech
Jan 26, 2026
Reiterates: Buy
Price Target: $36
Current: $19.20
Upside: +87.50%
Lipocine
Jan 21, 2026
Maintains: Buy
Price Target: $7 → $15
Current: $8.19
Upside: +83.15%
Jan 9, 2026
Reiterates: Buy
Price Target: $3 → $1
Current: $0.21
Upside: +383.09%
Dec 30, 2025
Maintains: Buy
Price Target: $39 → $50
Current: $24.67
Upside: +102.68%
Dec 29, 2025
Reiterates: Buy
Price Target: $32
Current: $20.12
Upside: +59.05%
Dec 26, 2025
Maintains: Buy
Price Target: $4 → $1.5
Current: $0.77
Upside: +93.82%
Dec 10, 2025
Maintains: Buy
Price Target: $2.5 → $5.5
Current: $1.40
Upside: +292.86%
Dec 8, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $10.33
Upside: +103.29%
Dec 5, 2025
Maintains: Buy
Price Target: $26 → $39
Current: $29.16
Upside: +33.74%
Nov 24, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $1.13
Upside: +519.47%
Nov 19, 2025
Maintains: Buy
Price Target: $13 → $9
Current: $3.00
Upside: +200.00%
Nov 17, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.20
Upside: +662.20%
Nov 17, 2025
Initiates: Buy
Price Target: $7
Current: $1.38
Upside: +407.25%
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.59
Upside: +576.93%
Nov 7, 2025
Maintains: Buy
Price Target: $98 → $89
Current: $53.05
Upside: +67.77%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $3.61
Upside: +38.50%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.65
Upside: +283.73%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.28
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $1.69
Upside: +314.20%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $2.89
Upside: +142.21%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.49
Upside: +122.72%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.03
Upside: +392.61%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.15
Upside: +247.83%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $2.62
Upside: +243.51%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $4.28
Upside: +86.92%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $10.87
Upside: +47.19%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $18.75
Upside: +33.33%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.17
Upside: +156.41%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.56
Upside: +1,071.88%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.81
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $2.00
Upside: +24,900.00%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $13.33
Upside: +260.09%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $115.24
Upside: -83.51%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.89
Upside: -